Skip to main content
Theranostics logoLink to Theranostics
. 2022 Apr 26;12(7):3582–3583. doi: 10.7150/thno.72572

Cardiomyocyte-Restricted Low Density Lipoprotein Receptor-Related Protein 6 (LRP6) Deletion Leads to Lethal Dilated Cardiomyopathy Partly Through Drp1 Signaling: Erratum

Zhidan Chen 1,#, Yang Li 1,#, Ying Wang 1,#, Juying Qian 1, Hong Ma 1, Xiang Wang 1, Guoliang Jiang 1, Ming Liu 1, Yanpeng An 2, Leilei Ma 1, Le Kang 1, Jianguo Jia 1, Chunjie Yang 1, Guoping Zhang 1, Ying Chen 3, Wei Gao 1, Mingqiang Fu 1, Zheyong Huang 1, Huiru Tang 2, Yichun Zhu 3, Junbo Ge 1, Hui Gong 1,, Yunzeng Zou 1,
PMCID: PMC9065206  PMID: 35547765

In the original publication, errors were regrettably found in Fig. 4A. The mistake was made during the figure arrangement. In Fig. 4A, the original bands of GAPDH were misused twice in two different treatment groups. We have checked the original bands and corrected them. The correction is shown below. The authors declare the amendments do not change the results and conclusions of the paper.

Figure 4.

Figure 4

Western blot analysis of LC3-II, PPARα, PPARδ, PGC1α and LC3b (LC3-I: the upper band; LC3-II: the down band) in heart tissue from diluent or tamoxifen-injected MCM or MCM/LRP6fl/fl mice.


Articles from Theranostics are provided here courtesy of Ivyspring International Publisher

RESOURCES